Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Probiotics for Anxiety and Depression: Side by Side with an Antidepressant

Official title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Clinical Efficacy and Safety of Probiotics in Participants With Anxiety Depression

Run by Moon (Guangzhou) Biotechnology Co., Ltd. · NCT07331987 · Data updated 2026-11-12

This study tests whether adding probiotics to treatment can help reduce anxiety and depression symptoms in adults compared with placebo, alongside traditional therapy, and checks safety and related biological markers.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment60 (estimated)
SponsorMoon (Guangzhou) Biotechnology Co., Ltd.
Industry-sponsored
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedJune 15, 2026
Main results expectedDecember 30, 2026
Study endsFebruary 28, 2027
Registry record updatedJune 29, 2026
Trial IDNCT07331987 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-60 with mild-to-moderate anxiety and/or depressive symptoms meeting DSM-5 criteria and HAM-D-24 ≥8 or HAM-A-14 ≥7 at screening.

Probably not a fit

Individuals with severe symptoms, current use of anxiolytics/antidepressants within 2 weeks (except escitalopram) or other exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind, placebo-controlled study will enroll 60 adults with mild-to-moderate anxiety and/or depression. Participants will be assigned to probiotic, placebo, or escitalopram, with a 3-month intervention and 1-month follow-up. The researchers will measure changes in anxiety and depression scores, sleep, and safety, and will explore possible mechanisms by analyzing serum biomarkers, gut microbiota, and related metabolites. The trial aims to determine if probiotics can help improve symptoms and what biological changes accompany any improvement.

Why it matters

Potential benefit: If successful, probiotics could offer an additional or adjunctive option for improving mood and anxiety with a favorable safety profile.

How similar studies have gone: Past studies have shown mixed results; this trial contributes new evidence by including biomarker analyses and a direct comparison with escitalopram.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\) Age: 18-60 years old; Gender: male or female.
* 2\) Meets the diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) for a mild-to-moderate depressive or anxiety symptoms.
* 3\) Hamilton Depression Rating Scale (HAM-D-24) score ≥ 8 or Hamilton Anxiety Rating Scale (HAM-A-14) score ≥ 7 at screening.
* 4\) Has no used of anxiolytic or antidepressant medications (including traditional Chinese patent medicines), with the exception of Escitalopram Oxalate, within 2 weeks prior to the first dose.
* 5\) For participants of childbearing potential (male or female): Must agree to use least one medically approve form of contraception (e.g., intrautering device \[IUD\], oral contraceptives, or condoms) throughout the trial. For female participants of childbearing potential: Must have a negative urine pregnancy test at screening and must be non-lactating.
* 6\) The participant is willing and be able to provide written informed consent to participate in the study.

Exclusion Criteria:

* 1\) HAM-D-24 score ≥ 35 or HAM-A-14 score ≥ 29.
* 2\) Presence of significant suicidal ideation.
* 3\) History or current diagnosis of neuropsychiatric disorders such as schizophrenia or epilepsy.
* 4\) History of head trauma (with loss of consciousness for \>10 minutes), other unstable major somatic diseases, or any somatic condition that could cause psychiatric symptoms.
* 5\) Suspected intellectual disability.
* 6\) History of alcohol or substance abuse prior to enrollment.
* 7\) Cranial magnetic resonance imaging (MRI) reveals organic lesions.
* 8\) Participants who are deemed unsuitable for the study by the investigator for any other reason.

Where it's running

  • The First Affiliated Hospital of Guangdong Pharmaceutical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.